Riera-Mestre A, Camafort M, Suriñach JM, Muñoz Rodriguez FJ, Padilla F, Francisco-Pascual J, Arranz JM, Martinez Rubio A, Villuendas Sabaté R, Freixa-Pamias R, Suarez C, Santamaría A. 204/20

Anticoagulation of the multipathological elderly patient with non-valvular atrial fibrillation: role of rivaroxaban.

Rev Esp Cardiol Suppl. 2020;19(A):3-10

de Frutos F, Mirabet S, Ortega-Paz L, Buera I, Darnés S, Farré N, Andrés B, Adeliño R, Bascompte R, Pérez-Rodón J, Aparicio X, Sutil-Vega M, Soto A, Faraudo M, Cainzos - Achirica M, and Manito N. 260/20

Management of Heart Failure with Reduced Ejection Fraction after ESC 2016 Heart Failure Guidelines: The Linx Registry.

ESC Heart Fail. 2020 Feb;7(1):25-35.

Yun S, Enjuanes C, Calero E, Hidalgo E, Cobo M, Llàcer P, García-Pinilla JM, González-Franco A, Núñez J, Morales-Rull JL, Beltrán P, Delso C, Freixa R, Moliner P, Corbella X , Comín-Colet J, HERMeS trial investigators group. 312/20

Study design of Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS).

ESC Heart Fail. 2020 Sep 17

Garcimartín P, Comín-Colet J, Pardo-Cladellas Y, Badosa N, Linas A, Rosenfeld L, Faraudo M, et al. 325/20

Validation of the Spanish version of the questionnaire on Patient Empowerment in Long-Term Conditions.

PLoS One. 2020 Jun 12; 15 (6): e0233338.

Freixa-Pamias R, Blanch Gràcia P, Rodríguez Latre ML, Basile L, Sánchez Chamero P, Gómez-Choco M, Armario P, Martínez-Rubio A, Lupón J; Working Group for coordination between Cardiology & Primary Care, Barcelona, ​​Spain. 251/20

Impact of prescription patterns of antithrombotic treatment on atrial fibrillation-related ischemic stroke.

Curr Med Res Opin. 2020 Dec 16; 1

Bonanad Lozano C, Díez-Villanueva P, García Blas S, Ayesta A, Ibars S, Ariza-Solé A, Ferreiro L, Moreno R, Roldán I, Marín F, Carol Ruiz A, García Pardo H, Sanchís J, Cruz-González I, Anguita M, Cequier A, Ruiz García J, Martínez-Sellés M. 248/20

Impact of antithrombotic treatment and geriatric syndromes in octogenarians with atrial fibrillation and ischemic heart disease. Atrial Fibrillation and Ischemic Heart Disease in the Elderly.

Anguita M, Bayés-Genís A, Cepeda JM, Cinza S, Cosín J, CrespoLeire M, Egocheaga I, Faraudo M, Garcia-Pinilla JM, Manzano L, Obaya JC, PascualFigal D, Segovia-Cubero J, Loza E. 216/ 20

Expert consensus on heart failure with reduced ejection fraction: beyond the guidelines.

1-3587(20)30016-9

Cosin-Sales J, Freixa R, Bravo M, Ruvira J, Blanch P, Calvo Iglesias FE, Escobar C. 250/20

Impact of different models of improvement of continuity of care on lipid control and the delay of visits to cardiology.

Future Cardiol. 2020 Jan;16(1):33-41

Mena Sebastiá E, Tirapu Sola L, Villanueva Vázquez R, Losa Gaspà F, Freixa-Pamias R. 210/20

Cancer, onco-hematological treatment and cardiovascular toxicity.

Vasc Hypertensive Risk 2020 Sep 23;S1889-1837(20)30083-0

Cortés Fernández MS, Monteys JP, Castellanos P, Armario P. 245/20

Malignant arterial hypertension (HTAM) with severe reversible left ventricular systolic dysfunction.

Vasc Hypertensive Risk Apr-Jun 2020;37(2):82-85.